Clinical Trial Update: Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This is a completed Phase 1 study evaluating fondaparinux (Arixtra) in combination with chemotherapy for patients with advanced non-small cell lung cancer and v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Venous Thromboembolism

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Non-Small Cell Lung Cancer, Venous Thromboembolism | Phase 1 | Status: COMPLETED